Yuxi Li - Publications

The bleeding risk of low-molecular-weight heparin bridging therapy in patients receiving preoperative oral antithrombotic drugs during spinal fusion surgery.

Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

Published: December 12, 2025

Identification and immune characteristics of N6-methyladenosine related ferroptosis-related genes in intervertebral disc degeneration.

Journal: Scientific reports

Published: February 16, 2025

FKBP5 promotes osteogenic differentiation of mesenchymal stem cells through type-I interferon pathway Inhibition.

Journal: Cellular and molecular life sciences : CMLS

Published: October 09, 2024

LncRNA MRF targeting FSHR inhibits the osteogenic differentiation of BMSCs and bone defect repair through the regulation of the cAMP-PKA-CREB signaling pathway.

Journal: Stem cell research & therapy

Published: July 24, 2024

LRP1 mitigates intervertebral disc degeneration by inhibiting endoplasmic reticulum stress through stabilizing the PPARγ.

Journal: Journal of orthopaedic translation

Published: June 16, 2024

Phillyrin reduces ROS production to alleviate the progression of intervertebral disc degeneration by inhibiting NF-κB pathway.

Journal: Journal of orthopaedic surgery and research

Published: January 16, 2024

The role of endoplasmic reticulum stress, mitochondrial dysfunction and their crosstalk in intervertebral disc degeneration.

Journal: Cellular signalling

Published: September 11, 2023

Emodin ameliorates matrix degradation and apoptosis in nucleus pulposus cells and attenuates intervertebral disc degeneration through LRP1 in vitro and in vivo.

Journal: Experimental cell research

Published: August 14, 2023

Comprehensive analysis of angiogenesis pattern and related immune landscape for individual treatment in osteosarcoma.

Journal: NPJ precision oncology

Published: February 21, 2023

A pharmacovigilance analysis of FDA adverse event reporting system events for romosozumab.

Journal: Expert opinion on drug safety

Published: September 30, 2022

TAK-715 alleviated IL-1β-induced apoptosis and ECM degradation in nucleus pulposus cells and attenuated intervertebral disc degeneration ex vivo and in vivo.

Journal: Arthritis research & therapy

Published: September 09, 2022

Biomechanical effects of cement discoplasty on the lumbar spinal unit.

Journal: Frontiers in surgery

Published: May 23, 2022